Economic evaluation of finotonlimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinoma
Table 3
Model Parameters.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Model Parameters.